GalenicaGALNF 80 Return-on-Tangible-Equity is 100.62% as of Dec. 2025, which is 9% above its 10-year median of 92.16. GuruFocus rates GALNF with a GF Score™ of 80/100 and a GF Value™ of $117.23. The stock has 1 warning sign investors should review. Among 113 Medical Distribution companies, Galenica ranks better than 84.07% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Galenica's annualized net income for the quarter that ended in Dec. 2025 was $233 Mil. Galenica's average shareholder tangible equity for the quarter that ended in Dec. 2025 was $232 Mil. Therefore, Galenica's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 100.62%.
The historical rank and industry rank for Galenica's Return-on-Tangible-Equity or its related term are showing as below:
GALNF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 44.31 Med: 92.16 Max: 123.77
Current: 67.24
During the past 13 years, Galenica's highest Return-on-Tangible-Equity was 123.77%. The lowest was 44.31%. And the median was 92.16%.
GALNF's Return-on-Tangible-Equity is ranked better than 84.07% of 113
companies
in the Medical Distribution industry
Industry Median: 9.07
vs GALNF: 67.24
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Galenica Return-on-Tangible-Equity Related Terms
Galenica Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Galenica's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GALNF vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Galenica's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galenica Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Galenica's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Galenica's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 100.62% mean?
Galenica (GALNF) has a Return-on-Tangible-Equity of 100.62% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Galenica and its competitors. This is near median its historical median of 92.16. Over the past decade, Galenica's Return-on-Tangible-Equity has ranged from 44.31 to 123.77. According to the industry distribution chart, Galenica ranks #18 out of 113 companies in the Medical Distribution industry, placing it in the top 15.9%.
Is Galenica's Return-on-Tangible-Equity too high?
Galenica's current Return-on-Tangible-Equity of 100.62% is near median its 10-year median of 92.16. Over the past 10 years, this metric has ranged from a low of 44.31 to a high of 123.77. The Medical Distribution industry median Return-on-Tangible-Equity is 9.07. Galenica's value of 100.62% is 1009.4% above this industry median. Based on the distribution chart, Galenica ranks #18 out of 113 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Galenica has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Galenica ranks #18 out of 113 companies for Return-on-Tangible-Equity. This places Galenica in the top 16% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 9.07. Galenica's value of 100.62% is 1009.4% above this benchmark. Historically, Galenica's own Return-on-Tangible-Equity has ranged from 44.31 to 123.77 over the past decade. While the company's 10-year median is 92.16 vs. the industry median of 9.07, Galenica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 9.07, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current Return-on-Tangible-Equity of 100.62% is 1009.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 9.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current Return-on-Tangible-Equity is 100.62%, which is near median its own 10-year median of 92.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current Return-on-Tangible-Equity of 100.62%. The stock's GF Value™ is $117.23, compared to a current price of $115.00 — trading 1.9% below its estimated fair value. The current Return-on-Tangible-Equity is 100.62%, which is near median its 10-year median of 92.16 and 1009.4% above the Medical Distribution industry median of 9.07. Galenica's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Galenica (GALNF), the current Return-on-Tangible-Equity is 100.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Galenica (GALNF) Overvalued in 2026?
Based on GuruFocus' analysis, Galenica stock appears to be undervalued.
The current stock price of $115.00 is trading 1.9% below its estimated GF Value™ of $117.23.
Key valuation signals for GALNF:
Return-on-Tangible-Equity: 100.62% (near median its 10-year median of 92.16)
GF Value™: $117.23 vs. price of $115.00 (1.9% below fair value)
Industry Position: 1009.4% above the Medical Distribution median (#18 of 113)
No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
80GF Score
Get the complete analysis for GALNF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GALNF has been successfully added to your 
